SUBSCRIBE
SUBSCRIBE
News   Deals

Reliant Pharmaceuticals, Inc. Sets IPO at 11.7 Million Shares, $25-$27

October 25, 2007 | 
1 min read

WASHINGTON, Oct 24 (Reuters) - Reliant Pharmaceuticals Inc on Wednesday set its planned initial public offering at 11.72 million shares for an estimated price of $25 to $27 each.

IPO
MORE ON THIS TOPIC
Handshake gesture contemporary collage art. Celebrating success, congratulating for financial and business partnership, job contract deal, mutual friendship and respect. Abstract illustration isolated.
Alzheimer’s disease
GSK Strikes Third Agreement This Week, Leans Further Into Neuro
December 5, 2024
 · 
2 min read
 · 
Tristan Manalac
GSK's headquarters office building in Poznan, Poland
ADCs
GSK Turns Back to China in Another Potential $1B+ ADC Deal
December 4, 2024
 · 
1 min read
 · 
Kate Goodwin
Crowdfunding concept with money icon and human hands in retro 80s collage mixed media vector illustration. Idea for financing business project, funding, philanthropy, cooperation, bank credit and startup development.
Series A
Obesity-Focused Antag Debuts With $84M and Backing From Novo Holdings
December 4, 2024
 · 
2 min read
 · 
Heather McKenzie
Roche's signage at its office in France
Immunology & inflammation
Roche Partners With COUR in Autoimmune Deal Potentially Worth More Than $900M
December 3, 2024
 · 
1 min read
 · 
Heather McKenzie